Page last updated: 2024-09-05

ly 300164 and Epilepsy

ly 300164 has been researched along with Epilepsy in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chimirri, A; De Sarro, A; De Sarro, G; Ferreri, G; Gitto, R; Orlando, V; Quartarone, S; Russo, E1
Aujla, PK; Fishman, R; Jensen, FE; Rakhade, SN; Sucher, NJ; Zhou, C1
Banczerowski-Pelyhe, I; Gulyás-Kovács, A; Takács, J; Tarnawa, I; Világi, I1
Jewell, H; Langan, YM; Lucas, R; Patsalos, PN; Sander, JW; Schaefer, H; Toublanc, N1
Bell, C; Howes, JF1
Gacsályi, I; Gigler, G; Gyertyán, I; Lévay, G; Szabados, T1

Reviews

1 review(s) available for ly 300164 and Epilepsy

ArticleYear
Talampanel.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2007, Volume: 4, Issue:1

    Topics: Animals; Antineoplastic Agents; Benzodiazepines; Brain; Clinical Trials as Topic; Epilepsy; Humans

2007

Trials

1 trial(s) available for ly 300164 and Epilepsy

ArticleYear
Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy.
    Epilepsia, 2003, Volume: 44, Issue:1

    Topics: Administration, Oral; Adult; Anticonvulsants; Area Under Curve; Benzodiazepines; Biological Availability; Chronic Disease; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged

2003

Other Studies

4 other study(ies) available for ly 300164 and Epilepsy

ArticleYear
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
    Journal of medicinal chemistry, 2003, Aug-14, Volume: 46, Issue:17

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Disease Models, Animal; Epilepsy; Excitatory Amino Acid Agonists; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred DBA; Neurons; Olfactory Pathways; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Structure-Activity Relationship; Triazoles

2003
Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Aug-06, Volume: 28, Issue:32

    Topics: Animals; Animals, Newborn; Anticonvulsants; Benzodiazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Disease Susceptibility; Enzyme Activation; Epilepsy; Excitatory Postsynaptic Potentials; Fructose; Hypoxia; Male; Phosphorylation; Protein Kinase C; Quinoxalines; Rats; Rats, Long-Evans; Receptors, AMPA; Synapses; Topiramate

2008
Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats.
    Brain research bulletin, 2002, Oct-15, Volume: 59, Issue:1

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; Anti-Anxiety Agents; Asphyxia Neonatorum; Behavior, Animal; Benzodiazepines; Cell Death; Epilepsy; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Male; Movement Disorders; Neostriatum; Neuroprotective Agents; Neurotoxins; Rats; Receptors, AMPA; Synaptic Transmission

2002
Duration of action of GYKI 52466 and its analogues in antiepileptic, anti-ischaemic and muscle relaxant tests.
    Neurobiology (Budapest, Hungary), 1999, Volume: 7, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Mice; Muscle Relaxants, Central

1999